Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival

被引:45
作者
Dabakuyo, T. S. [1 ,5 ]
Bonnetain, F. [1 ,5 ]
Roignot, P. [2 ]
Poillot, M. -L. [1 ,5 ]
Chaplain, G. [1 ]
Altwegg, T. [3 ]
Hedelin, G. [4 ]
Arveux, P. [1 ,5 ]
机构
[1] Ctr Georges Francois Leclerc, Breast & Gynaecol Canc Registry Cote Or, F-21000 Dijon, France
[2] Ctr Pathol, Dijon, France
[3] Ctr Radiotherapie Du Parc, Dijon, France
[4] Univ Strasbourg, Fac Med, Dept Epidemiol & Publ Hlth, F-67070 Strasbourg, France
[5] Univ Burgundy, Fac Med, EA 4184, Dijon, France
关键词
breast cancer; crude survival; epidemiology; population-based cancer registry; prognostic factors; relative survival; AXILLARY LYMPH-NODES; NUMBER; STAGE; AGE; CARCINOMA; MORTALITY; EUROPE; SIZE;
D O I
10.1093/annonc/mdm491
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Few population-based studies have reported jointly analyses of relative survival according to the following prognostic factors: tumour-node-metastasis (TNM) stage, age, number of examined and positive nodes, hormonal status, histological Scarff, Bloom and Richardson (SBR) grade, tumour extension, hormone receptor status and tumour multifocal status. Patients and methods: Data on female invasive breast cancer were provided by the Cote d'Or breast cancer registry. The Kaplan-Meier method and log-rank test were used to estimate and compare the survival probability at 1, 5, 10 and 15 years. The effect of prognostic factors on survival was assessed with crude and relative multivariate survival analyses. Results: Crude survival seemed to be worse in patients aged >60 years compared with those aged 45-60 (P > 0.0001), whereas relative survival did not differ. TNM stage, histological SBR grade, progesterone receptor status, tumour multifocal status, locoregional extension and the period of diagnosis were independent prognostic factors of crude and relative survival. Conclusion: Breast cancer is influenced by many factors. Despite the absence of any association between the number of examined nodes and overall survival in this study, the number of nodes removed, in conjunction with other prognostic factors, may be useful in selecting node-negative patients for systemic therapy.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 33 条
[1]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[2]  
Black RJ, 1998, IARC SCI PUBLICATION, V145
[3]   Cancer incidence and mortality in Europe, 2004 [J].
Boyle, P ;
Ferlay, J .
ANNALS OF ONCOLOGY, 2005, 16 (03) :481-488
[4]   Are patients diagnosed with breast cancer before age 50 years ever cured? [J].
Brenner, H ;
Hakulinen, T .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :432-438
[5]  
Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
[6]  
Camp RL, 2000, CANCER, V88, P108, DOI 10.1002/(SICI)1097-0142(20000101)88:1<108::AID-CNCR15>3.0.CO
[7]  
2-B
[8]   Population-based cancer survival in Singapore, 1968 to 1992: An overview [J].
Chia, KS ;
Du, WB ;
Sankaranarayanan, R ;
Sankila, R ;
Seow, A ;
Lee, HP .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) :142-147
[9]  
Clarke M, 1998, LANCET, V351, P1451
[10]   Regression models for relative survival [J].
Dickman, PW ;
Sloggett, A ;
Hills, M ;
Hakulinen, T .
STATISTICS IN MEDICINE, 2004, 23 (01) :51-64